--- title: Biologics (Monoclonal Antibodies) CROs path: /modalities/biologics-monoclonal-antibodies companies_count: 63 --- # Biologics (Monoclonal Antibodies) CROs 63 published CROs match Biologics (Monoclonal Antibodies). Locations in this set include United States, China, United Kingdom, Australia, Germany, and India. Capabilities that show up most often in this set: Bioanalysis, Biomarker Assays, Preclinical In Vivo Studies, Translational Research, and In Vitro Pharmacology. ## Matching companies - [ACM Global Laboratories](/companies/acmgloballab) - Global clinical trial central lab and bioanalytical services provider with 40+ years of experience supporting drug development across 65+ countries. - [Abzena](/companies/abzena) - Fully integrated biologics and bioconjugates CDMO+CRO offering drug design, development, and GMP manufacturing for antibodies, ADCs, AOCs, RDCs, and vaccines from discovery through commercial scale. - [Accelagen, Inc.](/companies/accelagen) - Accelagen is a Gene-to-Protein company providing protein expression, purification, and molecular biology services across baculovirus, mammalian, and E. coli systems. - [Accelsiors](/companies/accelsiors) - Full-service CRO providing clinical trial management, regulatory consulting, pharmacovigilance, biostatistics, and medical writing across 40+ countries with AI-secure eClinical systems and patient-centered trial design. - [Aliri Bioanalysis](/companies/aliribio) - Bioanalytical CRO specializing in PK/PD, biomarker, and spatial imaging services across discovery through Phase 3 clinical trials, with 20+ years of regulatory expertise. - [Alloy Therapeutics](/companies/alloytx) - Product development organization offering AI/ML-driven antibody and multispecific discovery, TCR mimic (TCRm) discovery, and antisense oligonucleotide design, backed by transgenic mouse platforms and pharmacology studies. - [Allucent](/companies/allucent) - Allucent is a full-service CRO specializing in clinical development solutions for small and mid-sized biotech companies. - [Aragen Life Sciences](/companies/aragen) - Global CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe. - [AvantGen, Inc.](/companies/avantgen) - AvantGen is a contract antibody discovery and engineering partner offering proprietary yeast display platforms for discovery, optimization, and development of novel antibody drugs. - [Axcelead Drug Discovery Partners, Inc.](/companies/axcelead) - Axcelead provides integrated drug discovery research services to pharmaceutical companies, biotech ventures, and academic institutions. Founded in 2017 from Takeda's drug discovery research base, the company offers expertise across small molecules, nucleic acids, antibodies, and multiple therapeutic modalities. - [BA Sciences](/companies/basciences) - A cGMP-compliant, FDA/DEA-registered, ISO/IEC-17025:2017 certified analytical testing laboratory. It offers analytical method development and validation, raw material and microbiology testing, extractables and leachables, nitrosamines testing, and stability testing for biopharmaceutical, pharmaceutical, and medical device clients. - [BioAgilytix](/companies/bioagilytix) - Bioanalytical CRO specializing in pharmacokinetics, immunogenicity, biomarkers, and CMC analytics with 30+ years of experience and 1,100+ employees conducting 5M+ tests annually. - [BioDuro-Sundia](/companies/bioduro-sundia) - BioDuro-Sundia is a contract research, development, and manufacturing organization (CRDMO) with 30 years of expertise providing integrated drug discovery, development, and manufacturing services from target identification through IND submission. - [Celerion](/companies/celerion) - Global CRO specializing in early-phase clinical research and bioanalytical sciences with 650+ beds across 30 countries and 50+ years of experience. - [Certara](/companies/certara) - Certara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making. - [Champions Oncology](/companies/championsoncology) - Leading oncology CRO specializing in preclinical and clinical specialty testing, with over 1,400 patient-derived xenograft models, comprehensive multi-omic datasets, and proprietary platforms including flow cytometry, NGS, proteomics, and histopathology services. - [Charles River Laboratories](/companies/criver) - Charles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years. - [ChemPartner](/companies/chempartner) - Global preclinical CRO with 20+ years of experience supporting drug discovery through IND submission across small molecules and biologics, with 2,000+ scientists and facilities worldwide. - [Clario](/companies/clario) - Clario provides comprehensive clinical trial endpoint solutions spanning cardiac safety, eCOA, medical imaging, respiratory, and precision motion analysis, supporting approximately 70% of FDA and EMA novel drug approvals over the past decade. - [Creative Bioarray](/companies/creative-bioarray) - Creative Bioarray provides preclinical research solutions including drug screening, ADME-PK, toxicity studies, and cell-based services across oncology, neurology, cardiovascular, and metabolic therapeutic areas.